Showing results (521-530 of 980) with videos related to
Sort By:
Pageof 98
Current Drug Safety|November 1, 2024
Facial Hyperpigmentation Following AdalimumabMahjoubi Yasmine Salem, Aouinti Imen, Dahmani Israa, et al.Current Drug Safety|October 1, 2024
Drug-Induced Mitochondrial Disruption in the Blood-Brain Barrier Cells: Overlooked Player in Drug Safety EvaluationEkramy ElmorsyCurrent Drug Safety|September 20, 2024
Possible Terbinafine and/or Itraconazole Induced Vasculitis - A Case StudySahil Kumar, Swetha Narayanan, Prasan Kumar Panda, et al.Current Drug Safety|November 7, 2024
Carbamazepine-induced Stevens-Johnson Syndrome: A Case Report with Review of the LiteratureArunkumar Subramanian, Rajamohamed Haitharali, Nirenjen S, et al.Current Drug Safety|September 10, 2024
Promoting Patient Engagement in Adverse Drug Reaction Reporting: A Novel Approach Utilizing Set Induction-Based Skill QuestionnairesSree Sudha T Y, Kusum Kumari, Hansraj Kumar, et al.Current Drug Safety|February 11, 2025
Extreme and Severe Systemic Pain Caused by Rifampicin: A Case Report of a Rare Allergic ReactionTong-Xin Li, Yan-Mei Xiong, Wen-Wan Gao, et al.Current Drug Safety|February 21, 2025
Opioid Use Disorders: Prevention, Diagnosis, and Treatment Strategies to Mitigate Addiction RisksUma Agarwal, Khushboo Singhal, Rajiv Kumar TonkCurrent Drug Safety|December 7, 2022
Manifestations, Prevalence, Management and Outcome of Invasive Aspergillosis in Post-Liver Transplant PatientsMohsen Aliakbarian, Rozita Khodashahi, Kambiz Akhavan Rezayat, et al.Current Drug Safety|January 23, 2019
Adverse Drug Reactions to Radiographic Contrast Media in a Teaching Hospital in North India: An Observational StudyDeepti Chopra, Abhinav Jain, Richa Garg, et al.Current Drug Safety|January 23, 2019
Depression, Antidepressants and Hypertensive Disorders of Pregnancy: A Systematic ReviewSabrina Youash, Verinder SharmaPageof 98